AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.

Plains All American Pipeline misses revenue but beats earnings in Q3 2024. Learn why PAA stock offers strong yield and ...

Trump's potential economic policies include tariffs, deregulation, and immigration reforms, which could impact inflation, job ...

Lumine Group is focused on acquiring and optimizing TMT software companies. Learn why LMGIF stock is a Hold for now, despite ...

Grupo Financiero Galicia is benefiting from a rebound in private sector lending activity in Argentina. Market forecasts see ...

Nextracker boasts strong fundamentals, including high profit margins, double-digit revenue growth, and a solid balance sheet, ...

Iovance Biotherapeutics' strong Q3 earnings and promising drug pipeline suggest growth potential for risk-tolerant investors.

Vale (NYSE:VALE) -3.6% in Monday's trading as UBS downgrades shares to Neutral from Buy with an $11.50 price target, cut from ...

Boeing's preferred stock offers a 5.6% yield with dividends paid quarterly starting January 2025. Read why mandatory ...

Global Net Lease has a Dividend Payout ratio of 150% and has negative 72% price returns since IPO. Read our full bear case ...

VanEck Fallen Angel High Yield Bond ETF offers a 6.32% SEC yield but has lagged inflation. Learn why ANGL ETF may be less ...

Savers Value Village, a major for-profit thrift retailer, shows modest revenue growth but mixed profitability, yet remains ...